최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기ACS biomaterials science & engineering, v.5 no.6, 2019년, pp.2899 - 2915
Roopmani, Purandhi (Department of Cardiology , Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER) , Pondicherry −) , Satheesh, Santhosh (605006 , India) , Raj, David C. , Krishnan, Uma Maheswari
The pleiotropic effects of the atorvastatin-fenofibrate combination can be effectively harnessed for site-specific therapy to minimize stent-related complications. The present study aims to utilize the pleiotropic effects of these two drugs entrapped in a uniform and defect-free coating of poly(L-la...
Exp Clin Cardiol Buttar H. S. 229 10 2005
Bønaa, Kaare H., Mannsverk, Jan, Wiseth, Rune, Aaberge, Lars, Myreng, Yngvar, Nygård, Ottar, Nilsen, Dennis W., Kløw, Nils-Einar, Uchto, Michael, Trovik, Thor, Bendz, Bjørn, Stavnes, Sindre, Bjørnerheim, Reidar, Larsen, Alf-Inge, Slette, Morten, Steigen, Terje, Jakobsen, Ole J., Bleie, Øyvind, Fossum, Eigil, Hanssen, Tove A., Dahl-Eriksen, Øystein, Njølstad, Inger, Rasmussen, Knut, Wilsgaard, Tom, Nordrehaug, Jan E.. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. The New England journal of medicine, vol.375, no.13, 1242-1252.
Celik, Turgay, Iyisoy, Atila, Kursaklioglu, Hurkan, Celik, Murat. The forgotten player of in-stent restenosis: Endothelial dysfunction. International journal of cardiology, vol.126, no.3, 443-444.
Georgiadou, Panagiota, Voudris, Vassilis. Platelet activation and stent thrombosis. Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē, vol.58, no.1, 49-50.
Warren, J., Baber, U., Mehran, R.. Antiplatelet therapy after drug-eluting stent implantation. Journal of cardiology, vol.65, no.2, 98-104.
Am. Fam Physician Dehmer G. J. 1245 80 2009
Pendyala, L.K., Yin, X., Li, J., Chen, J.P., Chronos, N., Hou, D.. The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction. JACC. Cardiovascular interventions, vol.2, no.12, 1169-1177.
Secemsky, Eric A., Yeh, Robert W., Kereiakes, Dean J., Cutlip, Donald E., Cohen, David J., Steg, P. Gabriel, Cannon, Christopher P., Apruzzese, Patricia K., D’Agostino Sr, Ralph B., Massaro, Joseph M., Mauri, Laura. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting : A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA cardiology, vol.2, no.5, 478-.
Muramatsu, T., Onuma, Y., Zhang, Y.J., Bourantas, C.V., Kharlamov, A., Diletti, R., Farooq, V., Gogas, B.D., Garg, S., Garcia-Garcia, H.M., Ozaki, Y., Serruys, P.W.. Progress in Treatment by Percutaneous Coronary Intervention: The Stent of the Future. Revista española de cardiología, vol.66, no.6, 483-496.
Harumi Higuchi dos Santos, Marilia, Sharma, Abhinav, Sun, Jie‐Lena, Pieper, Karen, McMurray, John J.V., Holman, Rury R., Lopes, Renato D.. International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial. Journal of the American Heart Association : cardiovascular and cerebrovascular disease, vol.6, no.1, e003892-.
Huang, Y., Ng, H.C.A., Ng, X.W., Subbu, V.. Drug-eluting biostable and erodible stents. Journal of controlled release : official journal of the Controlled Release Society, vol.193, 188-201.
Herrmann, R., Schmidmaier, G., Märkl, B., Resch, A., Hähnel, I., Stemberger, A., Alt, E.. Antithrombogenic Coating of Stents Using a Biodegradable Drug Delivery Technology. Thrombosis and haemostasis, vol.82, no.7, 51-57.
Berg, Ryan, Aragon, Joseph, Royter, Vladimir, Shanley, John F., Cogert, Greg, Vermani, Renu, Kar, Saibal, Eigler, Neal, Litvack, Frank. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, vol.70, no.6, 871-879.
Adriaenssens, T., Mehilli, J., Wessely, R., Ndrepepa, G., Seyfarth, M., Wieczorek, A., Blaich, B., Iijima, R., Pache, J., Kastrati, A., Schomig, A.. Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting Stent?. Journal of the American College of Cardiology, vol.49, no.12, 1265-1271.
Thipparaboina, R., Khan, W., Domb, A.J.. Eluting combination drugs from stents. International journal of pharmaceutics, vol.454, no.1, 4-10.
Ma, X., Oyamada, S., Gao, F., Wu, T., Robich, M.P., Wu, H., Wang, X., Buchholz, B., McCarthy, S., Gu, Z., Bianchi, C.F., Sellke, F.W., Laham, R.. Paclitaxel/sirolimus combination coated drug-eluting stent: In vitro and in vivo drug release studies. Journal of pharmaceutical and biomedical analysis, vol.54, no.4, 807-811.
Raber, L., Serruys, P.W.. Late Vascular Response Following Drug-Eluting Stent Implantation. JACC. Cardiovascular interventions, vol.4, no.10, 1075-1078.
Han, Seung Hwan, Quon, Michael J., Koh, Kwang Kon. Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor-α Activators. Hypertension, vol.46, no.5, 1086-1092.
Ortego, Mónica, Bustos, Carmen, Hernández-Presa, Miguel A, Tuñón, José, Dı́az, Cristina, Hernández, Gonzalo, Egido, Jesús. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis, vol.147, no.2, 253-261.
Li, Jingjing, Jiang, Jixin, Yin, Hao, Wang, Lifeng, Tian, Ruijuan, Li, Haijie, Wang, Zengyong, Li, Dong, Wang, Yuebing, Gui, Yu, Walsh, Michael P., Zheng, Xi-Long. Atorvastatin Inhibits Myocardin Expression in Vascular Smooth Muscle Cells. Hypertension, vol.60, no.1, 145-153.
Yin, Hao, Gui, Yu, Zheng, Xi-Long. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells. Journal of cellular physiology, vol.222, no.3, 556-564.
Li, Min, Liu, Yinglin, Dutt, Parmesh, Fanburg, Barry L., Toksoz, Deniz. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin. American journal of physiology. Lung cellular and molecular physiology, vol.293, no.2, L463-L471.
Chen, Shuang, Liu, Baoqin, Kong, Dehui, Li, Si, Li, Chao, Wang, Huaqin, Sun, Yingxian. Atorvastatin Calcium Inhibits Phenotypic Modulation of PDGF-BB-Induced VSMCs via Down-Regulation the Akt Signaling Pathway. PloS one, vol.10, no.4, e0122577-.
Int. J. Clin Exp Med. Li C. Y. 220824 9 2016
J. Physiol Pharmacol. Zemankova L. 403 66 2015
Xiao, Hongbing, Qin, Xiong, Ping, Ding, Zuo, Keqiang. Inhibition of Rho and Rac Geranylgeranylation by Atorvastatin Is Critical for Preservation of Endothelial Junction Integrity. PloS one, vol.8, no.3, e59233-.
Llevadot, Joan, Asahara, Takayuki. Efecto de las estatinas en la inducción de angiogénesis y vasculogénesis. Revista española de cardiología : publicación oficial de la Sociedad Española de Cardiología, vol.55, no.8, 838-844.
Antonopoulos, Alexios S, Margaritis, Marios, Lee, Regent, Channon, Keith, Antoniades, Charalambos. Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials. Current pharmaceutical design, vol.18, no.11, 1519-1530.
Feng, B., Xu, L., Wang, H., Yan, X., Xue, J., Liu, F., Hu, J.F.. Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. Biochimica et biophysica acta. Molecular basis of disease, vol.1812, no.9, 1130-1137.
Noonan, Jonathan E., Jenkins, Alicia J., Ma, Jian-Xing, Keech, Anthony C., Wang, Jie Jin, Lamoureux, Ecosse L.. An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes. Diabetes, vol.62, no.12, 3968-3975.
Pascal, M., Sepulchre, C., Chazan, J.B., Majoie, B.. Evidence for the inhibition of platelet-derived growth factor induced rat smooth muscle cells DNA synthesis by fenofibric acid at the Go/G1 cell cycle level. Life sciences, vol.33, no.10, 925-933.
Nigro, J., Ballinger, M. L., Dilley, R. J., Jennings, G. L. R., Wight, T. N., Little, P. J.. Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding. Diabetologia, vol.47, no.12, 2105-2113.
Lee, J.J., Jin, Y.R., Yu, J.Y., Munkhtsetseg, T., Park, E.S., Lim, Y., Kim, T.J., Pyo, M.Y., Hong, J.T., Yoo, H.S., Kim, Y., Yun, Y.P.. Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug. Atherosclerosis, vol.206, no.2, 375-382.
Diep, Quy N., Amiri, Farhad, Touyz, Rhian M., Cohn, Jeffrey S., Endemann, Dierk, Neves, Mario Fritsch, Schiffrin, Ernesto L.. PPARα Activator Effects on Ang II-Induced Vascular Oxidative Stress and Inflammation. Hypertension, vol.40, no.6, 866-871.
Rodriguez-Granillo, Agustina, Rubilar, Bibiana, Rodriguez-Granillo, Gaston, Rodriguez, Alfredo E. Advantages and disadvantages of biodegradable platforms in drug eluting stents.. World journal of cardiology, vol.3, no.3, 84-92.
Fernandez, J., Etxeberria, A., Ugartemendia, J.M., Petisco, S., Sarasua, J.R.. Effects of chain microstructures on mechanical behavior and aging of a poly(L-lactide-co-ε-caprolactone) biomedical thermoplastic-elastomer. Journal of the mechanical behavior of biomedical materials, vol.12, 29-38.
Bose, Sanjukta, Keller, Stephan S., Alstrøm, Tommy S., Boisen, Anja, Almdal, Kristoffer. Process Optimization of Ultrasonic Spray Coating of Polymer Films. Langmuir : the ACS journal of surfaces and colloids, vol.29, no.23, 6911-6919.
Routledge, Thomas J., Lidzey, David G., Buckley, Alastair R.. Ultrasonic spray coating as an approach for large-area polymer OLEDs: The influence of thin film processing and surface roughness on electrical performance. AIP advances, vol.9, no.1, 015330-.
Shanshan, C., Lili, T., Yingxue, T., Bingchun, Z., Ke, Y.. Study of drug-eluting coating on metal coronary stent. Materials science & engineering. C, Materials for biological applications, vol.33, no.3, 1476-1480.
Mohan, A., Narayanan, S., Balasubramanian, G., Sethuraman, S., Krishnan, U.M.. Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, vol.99, 73-83.
Ramana, L.N., Sharma, S., Sethuraman, S., Ranga, U., Krishnan, U.M.. Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs - Modern Trojan horses to combat HIV. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, vol.89, 300-311.
Biggs, Kevin B., Balss, Karin M., Maryanoff, Cynthia A.. Pore Networks and Polymer Rearrangement on a Drug-Eluting Stent as Revealed by Correlated Confocal Raman and Atomic Force Microscopy. Langmuir : the ACS journal of surfaces and colloids, vol.28, no.21, 8238-8243.
Jelonek, Katarzyna, Kasperczyk, Janusz, Li, Suming, Dobrzynski, Piotr, Janeczek, Henryk, Jarzabek, Bozena. Novel Poly(L-lactide-co- ε -caprolactone) Matrices Obtained with the Use of Zr[Acac] 4 as Nontoxic Initiator for Long-Term Release of Immunosuppressive Drugs. BioMed research international, vol.2013, 607351-.
Mikhalovska, Lyuba, Santin, Matteo, Denyer, Stephen, Lloyd, Andrew, G.Teer, Dennis, Field, Sue, Mikhalovsky, Sergey. Fibrinogen adsorption and platelet adhesion to metal and carbon coatings. Thrombosis and haemostasis, vol.92, no.5, 1032-1039.
Rodriguez, April L., Wojcik, Brandon M., Wrobleski, Shirley K., Myers Jr., Daniel D., Wakefield, Thomas W., Diaz, Jose A.. Statins, inflammation and deep vein thrombosis: a systematic review. Journal of thrombosis and thrombolysis, vol.33, no.4, 371-382.
Ali, Ferhana Y., Armstrong, Paul C.J., Dhanji, Al-Rehan A., Tucker, Arthur T., Paul-Clark, Mark J., Mitchell, Jane A., Warner, Timothy D.. Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs. Arteriosclerosis, thrombosis, and vascular biology, vol.29, no.5, 706-711.
Violi, Francesco, Calvieri, Camilla, Ferro, Domenico, Pignatelli, Pasquale. Statins as Antithrombotic Drugs. Circulation, vol.127, no.2, 251-257.
Kadikoylu, Gurhan, Yukselen, Vahit, Yavasoglu, Irfan, Bolaman, Zahit. Hemostatic Effects of Atorvastatin versus Simvastatin. The Annals of pharmacotherapy, vol.37, no.4, 478-484.
Cabanel, Mariana, Brand, Camila, Oliveira-Nunes, Maria Cecilia, Cabral-Piccin, Mariela Pires, Lopes, Marcela Freitas, Brito, Jose Marques, de Oliveira, Felipe Leite, El-Cheikh, Marcia Cury, Carneiro, Katia. Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PloS one, vol.10, no.7, e0132984-.
Liu, Yan-Cun, Zou, Xian-Biao, Chai, Yan-Fen, Yao, Yong-Ming. Macrophage Polarization in Inflammatory Diseases. International journal of biological sciences, vol.10, no.5, 520-529.
Roopmani, Purandhi, Krishnan, Uma Maheswari. Harnessing the pleiotropic effects of atorvastatin-fenofibrate combination for cardiovascular stents. Materials science & engineering. C, Materials for biological applications, vol.92, 875-891.
Hogue, Jean-Charles, Lamarche, Benoît, Tremblay, André J., Bergeron, Jean, Gagné, Claude, Couture, Patrick. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus. Metabolism : clinical and experimental, vol.57, no.3, 380-386.
Tsimihodimos, Vasilis, Kostoula, Angeliki, Kakafika, Anna, Bairaktari, Eleni, Tselepis, Alexandros D., Mikhailidis, Dimitri P., Elisaf, Moses. Effect of Fenofibrate on Serum Inflammatory Markers in Patients With High Triglyceride Values. Journal of cardiovascular pharmacology and therapeutics, vol.9, no.1, 27-33.
WANG, X.Q., LUO, N.S., CHEN, Z.Q., LIN, Y.Q., GU, M.N., CHEN, Y.X.. Atorvastatin Attenuates TNF-alpha Production via Heme Oxygenase-1 Pathway in LPS-stimulated RAW264.7 Macrophages. Biomedical and environmental sciences : BES = 生物醫學與環境科學 (英文版), vol.27, no.10, 786-793.
Paukkeri, E-L, Leppänen, T, Sareila, O, Vuolteenaho, K, Kankaanranta, H, Moilanen, E. PPARα agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. British journal of pharmacology : BJP, vol.152, no.7, 1081-1091.
Simon, Daniel I.. Inflammation and Vascular Injury : - Basic Discovery to Drug Development -. Circulation journal : official journal of the Japanese Circulation Society, vol.76, no.8, 1811-1818.
Björkhem‐Bergman, Linda, Lindh, Jonatan D., Bergman, Peter. What is a relevant statin concentration in cell experiments claiming pleiotropic effects?. British journal of clinical pharmacology, vol.72, no.1, 164-165.
Krysiak, Robert, Gdula-Dymek, Anna, Bachowski, Ryszard, Okopień, Bogusław. Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes. Diabetes care, vol.33, no.10, 2266-2270.
Tex Heart Inst J. Elieson M. 884 39 2012
Lai, Chih-Hung, Lin, Yung-Kai, Lee, Wen-Lieng, Chang, Wei-Chun. Coronary Stent Infection Presented as Recurrent Stent Thrombosis. Yonsei medical journal, vol.58, no.2, 458-461.
Ko, Humphrey H.T., Lareu, Ricky R., Dix, Brett R., Hughes, Jeffery D.. Statins: antimicrobial resistance breakers or makers?. PeerJ, vol.5, e3952-.
Muhlestein, J.B., May, H.T., Jensen, J.R., Horne, B.D., Lanman, R.B., Lavasani, F., Wolfert, R.L., Pearson, R.R., Yannicelli, H.D., Anderson, J.L.. The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia. Journal of the American College of Cardiology, vol.48, no.2, 396-401.
Bessler, Hanna, Salman, Hertzel, Bergman, Michael, Straussberg, Rachel, Djaldetti, Meir. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells. Clinical immunology : the official journal of the Clinical Immunology Society, vol.117, no.1, 73-77.
Won, Tae Wan. Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver. Korean journal of hepato-biliary-pancreatic surgery, vol.17, no.3, 89-108.
J. Physiol. Pharmacol. Mason R. P. 65 66 2015
Feng, Xiaomeng, Gao, Xia, Jia, Yumei, Zhang, Heng, Xu, Yuan, Wang, Guang. PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia. Medical science monitor : international medical journal of experimental and clinical research, vol.22, 743-751.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.